The company’s antibody e-commerce site facilitates academic and industry collaborations and provides a platform for thought leaders in the life science industry. The new platform provides researchers relevant information prior to ordering antibodies or contract research.
“Rockland’s technology platform brings together and leverages the distinct perspectives of scientists from academia, non-profit organizations and the private sector to foster multi-institutional and trans-disciplinary partnerships,” commented James Fendrick, CEO and President of Rockland. “The global biological research market is valued at 30 billion with a CAGR of 8.4% over the next 5 years. Facilitating scientific collaboration and customer input to provide researchers with the most relevant choice of product is Rockland’s primary goal”
In 2012, Rockland celebrates 50 years of service to the life science industry, providing scientists with antibodies and antibody based tools for cancer, cell biology, cell signaling and neuroscience research that are guaranteed to give predictable, repeatable results.
About Rockland
For 50 years, Rockland has supported the biopharma and diagnostic industries with antibodies and antibody based tools™ for basic research, assay development, and preclinical studies. With manufacturing facilities in Pennsylvania, Rockland is engaged in the development of new technologies for the production of antibodies for western blotting, immunohistochemistry (IHC), immunofluorescence microscopy, ELISA and FLOW cytometry. More information about Rockland products and services can be found at the company’s web site at http://www.rockland-inc.com/.
For additional information regarding this announcement, please contact:
Tabitha Patrick
Communications, Rockland Immunochemicals Inc.
Phone: 610.369.1008
Email: patrick@rockland-inc.com
Like Rockland On Facebook
